Over ten years experience in drug discovery research for the development of novel treatments in CNS disorders using a multi-disciplinary approach with strong knowledge and skills in electrophysiological, EEG, molecular, behavioral and data sciences.Published 20+ first author research papers, peer reviewer, outstanding oral communications and writing skills along with the ability to communicate to both scientific and lay audiences. Areas of expertise include client/customer management, periodic customer review engagements, internal team leadership, and cross functional project execution.Highly analytical and motivated scientist in the field of neurodegenerative disorders, primarily Alzhiemer’s, Parkinsons and Huntington’s Disease. Proven expertise of working with electrophysiological, EEG, and molecular biomarkers for various CNS disorders, including evaluation of molecular biomarkers like BACE1, Amyloid and synaptic proteins, and EEG biomarkers for pain. Well-developed expertise in translational preclinical research studies involving testing of compounds on rodent models of neurological disorders along with a track record of success managing complex technical, scientific and operational activities. Value-adding skills in molecular biology and biochemistry techniques, behavioral, morphological, electrophysiological, and EEG studies.